Table 1.
Demografic and spirometric data patients with IPF and sarcoidosis
| Sarcoidosis total | IPF | Controls | |
|---|---|---|---|
| N = 43 (20 F/ 23 M) | N = 17 (7 F/ 10 M) | N = 20 (10 F/10 M) | |
| (mean ± SEM) | (mean ± SEM) | (mean ± SEM) | |
| Median (Interquartile range) | Median (Interquartile range) | Median (Interquartile range) | |
| Age (years) | |||
| 35.7 ± 1.3 | 58.3 ± 1.6 *** | 34.3 ± 1.2 | |
| 33.5 (29.5–40.0) | 58.0 (53.7–64.0) | 33.5 (29.5–37.5) | |
| BMI (kg/m2) | 26.9 ± 0.5 | 27.4 ± 0.7 | 27.2 ± 0.6 |
| 27.0 (23.2–31.4) | 27.6 (21.2–31.3) | 27.1 (22.3–30.1) | |
| FEV1 (% of predicted) | |||
| 86.1 ± 1.6 | 67.9 ± 2.3 ** | ||
| 85.5 (81.0–93.0) | 69.0 (61.0–77.3) | ||
| FVC (% of predicted) | |||
| 96.2 ± 2.1 | 70.3 ± 1.8 ** | ||
| 98.0 (88.5–104.0) | 69.0 (63.5–79.0) | ||
| FEV1%VC (%) | |||
| 75.7 1.0 | 77.0 ± 1.8 | ||
| 75.0 (71.0–80.0) | 76 (73.5–82.3) |
F females, M males, IPF idiopathic pulmonary fibrosis, FEV1 Forced expiratory volume in 1 s
FVC Forced Vital Capacity, FEV1%VC forced expiratory volume in one second % of vital capacity **p < 0.001 IPF vs sarcoidosis ***p < 0.001 IPF vs controls and sarcoidosis